N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

C41H45F2N11O5S — CID 176674237

IUPACN-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESO=C1CC[C@@H](N2C(=O)c3cc(N4C[C@H]5C[C@@H]4CN5CC4CCC(n5cc(NC(=O)c6c(N7C[C@H]8C[C@@H]7CO8)nn7cccnc67)c(C(F)F)n5)CC4)ccc3[C@H]2S)C(=O)N1
InChIInChI=1S/C41H45F2N11O5S/c42-35(43)34-30(45-39(57)33-36-44-10-1-11-52(36)48-37(33)51-18-27-13-26(51)20-59-27)19-53(47-34)22-4-2-21(3-5-22)15-49-16-25-12-24(49)17-50(25)23-6-7-28-29(14-23)40(58)54(41(28)60)31-8-9-32(55)46-38(31)56/h1,6-7,10-11,14,19,21-22,24-27,31,35,41,60H,2-5,8-9,12-13,15-18,20H2,(H,45,57)(H,46,55,56)/t21?,22?,24-,25-,26-,27-,31-,41-/m1/s1
InChIKeyPIAWQSBDZNBGAB-UVOAELJGSA-N
MW841.95 g/mol
LogP3.98
Rot. Bonds9

About N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 176674237) has the molecular formula C41H45F2N11O5S and a molecular weight of 841.95 g/mol. Its IUPAC name is N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.

Molecular Properties

Compound NameN-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
PubChem CID176674237
Molecular FormulaC41H45F2N11O5S
Molecular Weight841.95 g/mol
Exact Mass841.33
IUPAC NameN-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESO=C1CC[C@@H](N2C(=O)c3cc(N4C[C@H]5C[C@@H]4CN5CC4CCC(n5cc(NC(=O)c6c(N7C[C@H]8C[C@@H]7CO8)nn7cccnc67)c(C(F)F)n5)CC4)ccc3[C@H]2S)C(=O)N1
InChIInChI=1S/C41H45F2N11O5S/c42-35(43)34-30(45-39(57)33-36-44-10-1-11-52(36)48-37(33)51-18-27-13-26(51)20-59-27)19-53(47-34)22-4-2-21(3-5-22)15-49-16-25-12-24(49)17-50(25)23-6-7-28-29(14-23)40(58)54(41(28)60)31-8-9-32(55)46-38(31)56/h1,6-7,10-11,14,19,21-22,24-27,31,35,41,60H,2-5,8-9,12-13,15-18,20H2,(H,45,57)(H,46,55,56)/t21?,22?,24-,25-,26-,27-,31-,41-/m1/s1
InChIKeyPIAWQSBDZNBGAB-UVOAELJGSA-N
XLogP3.98
TPSA162.54 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds9
Heavy Atoms60
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500841.95
LogP ≤ 53.98
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_D(198)', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'thiol_2', 'substructure': 'N/A'}

Analyze N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 176674237) is N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is O=C1CC[C@@H](N2C(=O)c3cc(N4C[C@H]5C[C@@H]4CN5CC4CCC(n5cc(NC(=O)c6c(N7C[C@H]8C[C@@H]7CO8)nn7cccnc67)c(C(F)F)n5)CC4)ccc3[C@H]2S)C(=O)N1.
What is the InChIKey of N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is PIAWQSBDZNBGAB-UVOAELJGSA-N. The full InChI is InChI=1S/C41H45F2N11O5S/c42-35(43)34-30(45-39(57)33-36-44-10-1-11-52(36)48-37(33)51-18-27-13-26(51)20-59-27)19-53(47-34)22-4-2-21(3-5-22)15-49-16-25-12-24(49)17-50(25)23-6-7-28-29(14-23)40(58)54(41(28)60)31-8-9-32(55)46-38(31)56/h1,6-7,10-11,14,19,21-22,24-27,31,35,41,60H,2-5,8-9,12-13,15-18,20H2,(H,45,57)(H,46,55,56)/t21?,22?,24-,25-,26-,27-,31-,41-/m1/s1.
What are the key properties of N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 841.95 g/mol, XLogP of 3.98, 9 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(difluoromethyl)-1-[4-[[(1R,4R)-5-[(1R)-2-[(3R)-2,6-dioxopiperidin-3-yl]-3-oxo-1-sulfanyl-1H-isoindol-5-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]cyclohexyl]pyrazol-4-yl]-2-[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 176674237), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).